Yanping Zhang,Xingge Lan,Yanan Wang,Yumeng Lin,Zhenghao Yu,Rongrong Guo,Kai Li,Hongyu Cui,Xiaole Qi,Yongqiang Wang,Li Gao,Qing Pan,Aijing Liu,Yulong Gao,Xiaomei Wang,Changjun Liu

Transbound Emerg Dis.2022 Mar 9.doi: 10.1111/tbed.14506. Online ahead of print.

Abstract

Marek's disease virus (MDV), an oncogenic virus belonging to the subfamily Alphaherpesvirinae, causes Marek's disease (MD). Vaccines can control MD, but cannot block the viral infection; they are considered imperfect vaccines, which carry the risk of recombination. In this study, six natural recombinant MDV strains were isolated from infected chickens in commercial flocks in China. We sequenced and analyzed the genetic characteristics of the isolates (HC/0803, CH/10, SY/1219, DH/1307, DH/1504, and Hrb/1504). We found that the six strains resulted from recombination between the vaccine CVI988/Rispens (CVI988) strain skeleton and the virulence strain's partial unique short region. Additionally, a pathogenicity study was performed on recombinant strains (HC/0803 and DH/1307) and reference strains (CVI988 and LHC2) to evaluate their virulence. LHC2 induced 84.6% mortality in infected chickens; however, no mortality was recorded in chickens inoculated with HC/0803, DH/1307, or CVI988. However, HC/0803 and DH/1307 induced a notable spleen enlargement, and mild thymus and bursa atrophy at 11-17 days post-challenge (dpc). The viral genome load in the HC/0803- and DH/1307-challenged chickens peaked at approximately 107 viral copies per million host cells at 17 dpc and was similar to that in LHC2-challenged chickens, but significantly higher than that of CVI988-challenged chickens. In summary, HC/0803 and DH/1307 displayed mild virulence with temporal damage to the immune organs of chicken and a higher reproduction capability than the vaccine strain CVI988. Our study provides direct evidence of the emergence of recombinant MDV strains between vaccine and virulence strains in nature. The emergence of natural recombinant strains suggests that live vaccines can act as genetic donors for genomic recombination, and recombination may be a safety concern when administering live vaccines. These findings demonstrate that recombination promotes genetic diversity and increases the complexity of disease diagnosis, prevention, and control. This article is protected by copyright. All rights reserved.

Keywords: Marek's disease virus; genetic diversity; pathogenicity; recombination; vaccine.

This article is protected by copyright. All rights reserved.